Health Care & Life Sciences » Pharmaceuticals | Chimerix Inc.

Chimerix Inc.

Chimerix Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 48.03 M
Public Float
 36.77 M
Chimerix Inc.
Stock Exchange NASDAQ Stock Market
EPS
 $1.37
Market Cap
 $205.82 M
Shares Outstanding
 51.07 M
Public Float
 44.26 M

Profile

Address
2505 Meridian Parkway
Durham North Carolina 27713
United States
Employees -
Website http://www.chimerix.com
Updated 07/08/2019
Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R.

Financials

View All
Created with Highcharts 5.0.14Chimerix Inc.Net Income. Fiscal year is January-December. All values USD Thousands.70 55370 55359 31259 312117 372117 37276 39076 39070 98470 98469 47469 474201320142015201620172018025k50k75k100k125k
Created with Highcharts 5.0.14Chimerix Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.4 3704 3704 0404 04010 76210 7625 7025 7024 4944 4947 2167 21620132014201520162017201802.5k5k7.5k10k12.5k

M. Michelle Berrey
President, Chief Executive Officer & Director
Martha J. Demski
Chairman
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.